Cargando…
Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926818/ https://www.ncbi.nlm.nih.gov/pubmed/36788609 http://dx.doi.org/10.1186/s13075-023-03005-x |
| _version_ | 1784888356005478400 |
|---|---|
| author | Ueno, Masanobu Miyagawa, Ippei Miyazaki, Yusuke Hanami, Kentaro Fukuyo, Shunsuke Kubo, Satoshi Nakayamada, Shingo Tanaka, Yoshiya |
| author_facet | Ueno, Masanobu Miyagawa, Ippei Miyazaki, Yusuke Hanami, Kentaro Fukuyo, Shunsuke Kubo, Satoshi Nakayamada, Shingo Tanaka, Yoshiya |
| author_sort | Ueno, Masanobu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9926818 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99268182023-02-15 Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes Ueno, Masanobu Miyagawa, Ippei Miyazaki, Yusuke Hanami, Kentaro Fukuyo, Shunsuke Kubo, Satoshi Nakayamada, Shingo Tanaka, Yoshiya Arthritis Res Ther Correction BioMed Central 2023-02-14 2023 /pmc/articles/PMC9926818/ /pubmed/36788609 http://dx.doi.org/10.1186/s13075-023-03005-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Ueno, Masanobu Miyagawa, Ippei Miyazaki, Yusuke Hanami, Kentaro Fukuyo, Shunsuke Kubo, Satoshi Nakayamada, Shingo Tanaka, Yoshiya Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes |
| title | Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes |
| title_full | Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes |
| title_fullStr | Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes |
| title_full_unstemmed | Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes |
| title_short | Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes |
| title_sort | correction: efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926818/ https://www.ncbi.nlm.nih.gov/pubmed/36788609 http://dx.doi.org/10.1186/s13075-023-03005-x |
| work_keys_str_mv | AT uenomasanobu correctionefficacyandsafetyofguselkumabandadalimumabforpustuloticarthroosteitisandtheirimpactonperipheralbloodimmunophenotypes AT miyagawaippei correctionefficacyandsafetyofguselkumabandadalimumabforpustuloticarthroosteitisandtheirimpactonperipheralbloodimmunophenotypes AT miyazakiyusuke correctionefficacyandsafetyofguselkumabandadalimumabforpustuloticarthroosteitisandtheirimpactonperipheralbloodimmunophenotypes AT hanamikentaro correctionefficacyandsafetyofguselkumabandadalimumabforpustuloticarthroosteitisandtheirimpactonperipheralbloodimmunophenotypes AT fukuyoshunsuke correctionefficacyandsafetyofguselkumabandadalimumabforpustuloticarthroosteitisandtheirimpactonperipheralbloodimmunophenotypes AT kubosatoshi correctionefficacyandsafetyofguselkumabandadalimumabforpustuloticarthroosteitisandtheirimpactonperipheralbloodimmunophenotypes AT nakayamadashingo correctionefficacyandsafetyofguselkumabandadalimumabforpustuloticarthroosteitisandtheirimpactonperipheralbloodimmunophenotypes AT tanakayoshiya correctionefficacyandsafetyofguselkumabandadalimumabforpustuloticarthroosteitisandtheirimpactonperipheralbloodimmunophenotypes |